Opto-electronic devices for the detection of cervical cancer - horizon scanning review
NHSC
Record ID 32001000990
English
Authors' objectives:
To summarise the current research evidence on the effectiveness of opto-electronic devices for the detection of cervical cancer.
Authors' recommendations:
- Clinical impact: Opto-electronic scanning appears to be a promising method (in terms of potential sensitivity and specificity, patient acceptability and timeliness) for cervical screening. Large multicentre trials are needed to further assess sensitivity and specificity in the UK setting, and determine its place and cost-effectiveness in any screening programme.
- Service impact: Widespread training in the use of these devices would be required if they were adopted within the current screening programme. The use of opto-electronic devices as a primary screening tool would require a significant re-organisation of the whole of the NHS Cervical Screening Programme. Use as a triage tool will be less disruptive and may reduce the number of referrals for colposcopy.
- Patient issues: Truscan has been shown (albeit in a relatively small study) to be more acceptable to patients than the conventional Pap smear. The timeliness of reporting of screening results may also be more acceptable than conventional techniques. It is hard to assess if widespread use of the device will positively affect uptake especially as the current method is consistently capturing over 80% of its target population.
- Financial and overall NHS impact: In the absence of cost data and without large UK-based multicentre trials it is difficult to predict the cost impact of these devices. Costs of any screening programme will also be very dependent on the programme use of such devices, i.e. triage, adjunct or direct replacement.
Authors' methods:
Overview
Details
Project Status:
Completed
Year Published:
2000
URL for published report:
http://www.hsric.nihr.ac.uk/search
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Costs and Cost Analysis
- Mass Screening
- Vaginal Smears
- Uterine Cervical Neoplasms
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
National Horizon Scanning Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.